AI-Powered Home Rehab Trial for MS Patients Promises New Hope for Mobility

A new chapter is opening for millions living with Multiple Sclerosis (MS) as the protocol for the PLATINUMS project, a pilot randomized controlled trial of an advanced AI-driven telerehabilitation system, was just published in PLOS One. This multinational study aims to test if a smart, home-based exercise program can significantly improve movement and balance for MS patients, potentially making specialized care far more accessible. The trial, set to recruit 96 participants soon, will compare this innovative AI platform against traditional paper-based exercises, marking a critical step toward future digital health solutions. Around 2.8 million people globally battle MS, a long-lasting disease that often leads to severe mobility impairments, making it tough to get to regular rehabilitation clinics. While telerehabilitation has shown promise, many existing systems are complex or lack personalized feedback, limiting their widespread use. The PLATINUMS project, funded by the European Partnership on Transforming Health and Care Systems, directly addresses these gaps by using Artificial Intelligence to offer tailored guidance and track progress through simple devices like phones or tablets, removing the need for extra, costly equipment. This approach aims to overcome barriers like distance and cost, empowering patients to manage their condition from home. With recruitment expected to wrap up by the end of 2026 and results anticipated in 2027, the healthcare world is keenly watching. If successful, the PLATINUMS project could pave the way for larger trials and revolutionize how physical therapy is delivered to those with chronic conditions, setting a new standard for accessible, effective, and personalized care. The findings will be crucial for understanding the real-world feasibility and benefits of advanced telerehabilitation, potentially improving quality of life for countless individuals.